Meritage Pharma, Inc.
9Patents
9Active
9Granted
45Portfolio score
Filing activity: Nov 12, 2008 → Mar 11, 2019 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8679545B2 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 23 | Active |
| US9782347B2 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 13 | Active |
| US10176301B2 | Systems, methods, and software for providing a patient-reported outcome measure of dysphagia patients with eosinophilic esophagitis | Physics | 12 | Active |
| US10272037B2 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 12 | Active |
| US9050368B2 | Corticosteroid compositions | Human Necessities | 5 | Active |
| US8865692B2 | Compositions for the treatment of gastrointestinal inflammation | Human Necessities | 5 | Active |
| US11413296B2 | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 0 | Active |
| US11197822B2 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 0 | Active |
| US10293052B2 | Compositions for the treatment of gastrointestinal inflammation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.